119th Congress · introduced in the House · Mar 10, 2025
Infant Formula Made in America Act of 2025
Official title from Congress.gov
Latest action (Mar 10, 2025): Referred to the House Committee on Ways and Means.
View on Congress.govPolicy area: Taxation
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the House Committee on Ways and Means.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
15 citations.
BUBS AUSTRALIA · lobbying firm or registrant: BONDI PARTNERS ADVOCACY CORP. (FKA PACIFIC PARTNERS)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Food Industry (safety, labeling, etc.)
$30,000
Paid to lobbying firm
Infant formula issues and legislation including H.R. 2008: Infant Formula Made in America Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BOBBIE BABY, INC. · lobbying firm or registrant: CORBIN STRATEGIES LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 9, 2026 · issue area: Manufacturing
$50,000
Paid to lobbying firm
…te for issues to promote manufacturing opportunities for small domestic infant formula producers, including ways to support the domestic dairy supply chain and H.R.2008, Infant Formula Made In America Act.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BOBBIE BABY, INC. · lobbying firm or registrant: CORBIN STRATEGIES LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 9, 2026 · issue area: Taxation/Internal Revenue Code
$50,000
Paid to lobbying firm
Advocate for infant formula manufacturing tax credits (H.R.2008, Infant Formula Made In America Act), impacts of tariffs on infant formula production, and health savings accounts.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BOBBIE BABY, INC. · lobbying firm or registrant: CORBIN STRATEGIES LLC
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · amended · posted Sep 22, 2026 · issue area: Taxation/Internal Revenue Code
$50,000
Paid to lobbying firm
Advocate for infant formula manufacturing tax credits (Infant Formula Made In America Act - H.R.2008) and infant formula access issues (health savings accounts).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BOBBIE BABY, INC. · lobbying firm or registrant: CORBIN STRATEGIES LLC
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · amended · posted Sep 22, 2026 · issue area: Taxation/Internal Revenue Code
$50,000
Paid to lobbying firm
Advocate for infant formula manufacturing tax credits (H.R.2008, Infant Formula Made In America Act), maternal health issues (H.R.5390/S.2823, FAMILY Act), and infant formula access issues (health savings accounts).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BOBBIE BABY, INC. · lobbying firm or registrant: CORBIN STRATEGIES LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · amended · posted Sep 22, 2026 · issue area: Taxation/Internal Revenue Code
$50,000
Paid to lobbying firm
Advocate for infant formula manufacturing tax credits (H.R.2008, Infant Formula Made In America Act), maternal health issues (H.R.5390/S.2823, FAMILY Act), and infant formula access issues (health savings accounts).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BOBBIE BABY, INC. · lobbying firm or registrant: CORBIN STRATEGIES LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · amended · posted Sep 22, 2026 · issue area: Manufacturing
$50,000
Paid to lobbying firm
Advocate for issues to promote manufacturing opportunities for small domestic infant formula producers; (H.R.2008, Infant Formula Made In America Act).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BOBBIE BABY, INC. · lobbying firm or registrant: CORBIN STRATEGIES LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 14, 2026 · issue area: Manufacturing
$50,000
Paid to lobbying firm
Advocate for issues to promote manufacturing opportunities for small domestic infant formula producers; (H.R.2008, Infant Formula Made In America Act).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BOBBIE BABY, INC. · lobbying firm or registrant: CORBIN STRATEGIES LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 14, 2026 · issue area: Taxation/Internal Revenue Code
$50,000
Paid to lobbying firm
Advocate for infant formula manufacturing tax credits (H.R.2008, Infant Formula Made In America Act).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
KELLEY, DRYE & WARREN LLP (OBO NARA ORGANICS) · lobbying firm or registrant: ROCK CREEK COUNSEL
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 7, 2026 · issue area: Taxation/Internal Revenue Code
$20,000
Paid to lobbying firm
Federal tax issues related to the manufacturing and domestic distribution of infant formula. H.R.2008 - Infant Formula Made in America Act of 2025.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
KELLEY, DRYE & WARREN LLP (OBO NARA ORGANICS) · lobbying firm or registrant: ROCK CREEK COUNSEL
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 20, 2025 · issue area: Taxation/Internal Revenue Code
$20,000
Paid to lobbying firm
Federal tax issues related to the manufacturing and domestic distribution of infant formula. H.R.2008 - Infant Formula Made in America Act of 2025.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
KELLEY, DRYE & WARREN LLP (OBO NARA ORGANICS) · lobbying firm or registrant: ROCK CREEK COUNSEL
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 21, 2025 · issue area: Taxation/Internal Revenue Code
$20,000
Paid to lobbying firm
Federal tax issues related to the manufacturing and domestic distribution of infant formula. H.R.2008 - Infant Formula Made in America Act of 2025.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BUBS AUSTRALIA · lobbying firm or registrant: BONDI PARTNERS ADVOCACY CORP. (FKA PACIFIC PARTNERS)
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 21, 2025 · issue area: Taxation/Internal Revenue Code
$30,000
Paid to lobbying firm
H.R. 2008: Infant Formula Made in America Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BUBS AUSTRALIA · lobbying firm or registrant: BONDI PARTNERS ADVOCACY CORP. (FKA PACIFIC PARTNERS)
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 21, 2025 · issue area: Food Industry (safety, labeling, etc.)
$30,000
Paid to lobbying firm
H.R. 2008: Infant Formula Made in America Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
KELLEY, DRYE & WARREN LLP (OBO NARA ORGANICS) · lobbying firm or registrant: ROCK CREEK COUNSEL
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 21, 2025 · issue area: Taxation/Internal Revenue Code
$10,000
Paid to lobbying firm
Federal tax issues related to the manufacturing and domestic distribution of infant formula. H.R.2008 - Infant Formula Made in America Act of 2025.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing